• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与单纯减肥相比,减肥联合渐进式抗阻训练对 2 型糖尿病老年患者脂肪肝指数的影响:一项为期 12 个月的随机对照试验的二次分析。

Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial.

机构信息

Institute for Physical Activity and Nutrition, Deakin University Faculty of Health, Geelong, Victoria, Australia.

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.

出版信息

BMJ Open Diabetes Res Care. 2022 Oct;10(5). doi: 10.1136/bmjdrc-2022-002950.

DOI:10.1136/bmjdrc-2022-002950
PMID:36220197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9557256/
Abstract

INTRODUCTION

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent (~75%) in people with type 2 diabetes (T2D). Since exercise and weight loss (WL) are recommended for the management of both NAFLD and T2D, this study examined whether progressive resistance training (PRT) plus WL could lead to greater improvements in the fatty liver index (FLI), an indicator of NAFLD, compared with WL alone in older adults with T2D.

RESEARCH DESIGN AND METHODS

This study represents a secondary analysis of a 12-month, two-arm randomised controlled trial including 36 overweight and obese adults (60-80 years) with T2D randomly allocated to supervised PRT plus WL (hypocaloric diet) (n=19) or WL plus sham (stretching) (n=17) for 6 months (phase I), followed by 6-months home-based training with ad libitum diet (phase II). FLI, which is an algorithm based on waist circumference, body mass index, triglycerides and gamma-glutamyl transferase, was assessed at baseline and every 3 months. Linear mixed models were used to analyse between-group differences over time, adjusting for baseline values.

RESULTS

At baseline, the mean±SD FLI was 76.6±18.5 and the likelihood of NAFLD (FLI >60) in all participants was 86%. Following phase I, both groups had similar statistically significant improvements in FLI (mean change (95% CI): PRT+WL, -12 (-20 to -4); WL, -9 (-15 to -4)), with no significant between-group difference. After the subsequent 6-month home-based phase, the improvements in FLI tended to persist in both groups (PRT+WL, -7 (-11 to -2); WL, -4 (-10 to 1)), with no between-group differences.

CONCLUSIONS

In older overweight adults with T2D, PRT did not enhance the benefits of WL on FLI, a predictor of NAFLD.

TRIAL REGISTRATION NUMBER

ACTRN12622000640707.

摘要

简介

非酒精性脂肪性肝病(NAFLD)在 2 型糖尿病(T2D)患者中非常普遍(~75%)。由于运动和体重减轻(WL)被推荐用于 NAFLD 和 T2D 的管理,因此本研究旨在检查在超重和肥胖的 T2D 成年人中,与单独 WL 相比,渐进式抗阻训练(PRT)加 WL 是否可以导致脂肪肝指数(FLI)的更大改善,FLI 是 NAFLD 的一个指标。

研究设计和方法

这是一项为期 12 个月的、双臂随机对照试验的二次分析,共纳入 36 名超重和肥胖的 T2D 成年人(60-80 岁),他们被随机分配接受监督 PRT 加 WL(低热量饮食)(n=19)或 WL 加假(伸展)(n=17)治疗 6 个月(第 I 阶段),随后进行 6 个月的家庭基础训练,饮食不限(第 II 阶段)。FLI 是一种基于腰围、体重指数、甘油三酯和γ-谷氨酰转移酶的算法,在基线和每 3 个月进行评估。线性混合模型用于分析随时间的组间差异,并调整基线值。

结果

在基线时,平均±SD FLI 为 76.6±18.5,所有参与者患 NAFLD(FLI>60)的可能性为 86%。第 I 阶段后,两组的 FLI 均有相似的统计学显著改善(PRT+WL 组的平均变化(95%CI):-12(-20 至-4);WL 组:-9(-15 至-4)),两组间无显著差异。在随后的 6 个月家庭基础阶段后,两组的 FLI 改善趋势均持续存在(PRT+WL 组:-7(-11 至-2);WL 组:-4(-10 至 1)),两组间无差异。

结论

在超重的 T2D 成年患者中,PRT 并未增强 WL 对 FLI 的益处,FLI 是 NAFLD 的预测指标。

试验注册

ACTRN12622000640707。

相似文献

1
Effect of progressive resistance training with weight loss compared with weight loss alone on the fatty liver index in older adults with type 2 diabetes: secondary analysis of a 12-month randomized controlled trial.与单纯减肥相比,减肥联合渐进式抗阻训练对 2 型糖尿病老年患者脂肪肝指数的影响:一项为期 12 个月的随机对照试验的二次分析。
BMJ Open Diabetes Res Care. 2022 Oct;10(5). doi: 10.1136/bmjdrc-2022-002950.
2
Effects of progressive resistance training and weight loss versus weight loss alone on inflammatory and endothelial biomarkers in older adults with type 2 diabetes.渐进性抗阻训练联合体重减轻与单纯体重减轻对老年2型糖尿病患者炎症和内皮生物标志物的影响。
Eur J Appl Physiol. 2017 Aug;117(8):1669-1678. doi: 10.1007/s00421-017-3657-2. Epub 2017 Jun 8.
3
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).脂肪肝指数可预测前驱糖尿病、2型糖尿病和非酒精性脂肪性肝病(NAFLD)的发病风险。
Ann Med. 2021 Dec;53(1):1256-1264. doi: 10.1080/07853890.2021.1956685.
4
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.基于地中海生活方式的干预对非酒精性脂肪性肝病患者临床特征的改善:一项随机对照临床试验。
Br J Nutr. 2018 Jul;120(2):164-175. doi: 10.1017/S000711451800137X.
5
Home-based resistance training is not sufficient to maintain improved glycemic control following supervised training in older individuals with type 2 diabetes.对于患有2型糖尿病的老年人,在家进行的抗阻训练不足以在监督训练后维持改善的血糖控制。
Diabetes Care. 2005 Jan;28(1):3-9. doi: 10.2337/diacare.28.1.3.
6
Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids.非酒精性脂肪性肝病与 2 型糖尿病发病风险:循环支链氨基酸的作用。
Nutrients. 2019 Mar 26;11(3):705. doi: 10.3390/nu11030705.
7
Effects of whey protein plus vitamin D supplementation combined with progressive resistance training on glycaemic control, body composition, muscle function and cardiometabolic risk factors in middle-aged and older overweight/obese adults with type 2 diabetes: A 24-week randomized controlled trial.乳清蛋白加维生素 D 补充剂联合渐进性抗阻训练对 2 型糖尿病中老年超重/肥胖患者血糖控制、身体成分、肌肉功能和心血管代谢危险因素的影响:一项 24 周随机对照试验。
Diabetes Obes Metab. 2021 Apr;23(4):938-949. doi: 10.1111/dom.14299. Epub 2021 Jan 19.
8
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病的脂肪肝指数与腰围对比
World J Gastroenterol. 2016 Mar 14;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023.
9
Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.艾塞那肽对2型糖尿病患者肥胖及伴有肝酶升高的非酒精性脂肪性肝病的益处。
Diabetes Metab Res Rev. 2014 Sep;30(6):521-9. doi: 10.1002/dmrr.2561.
10
Volume-dependent effect of supervised exercise training on fatty liver and visceral adiposity index in subjects with type 2 diabetes The Italian Diabetes Exercise Study (IDES).2 型糖尿病患者监督运动训练对脂肪肝和内脏脂肪指数的容量依赖性影响:意大利糖尿病运动研究(IDES)。
Diabetes Res Clin Pract. 2015 Aug;109(2):355-63. doi: 10.1016/j.diabres.2015.05.033. Epub 2015 May 18.

引用本文的文献

1
Physical Exercise as a Therapeutic Approach for Patients Living with Type 2 Diabetes: Does the Explanation Reside in Exerkines?-A Review.体育锻炼作为2型糖尿病患者的一种治疗方法:解释是否在于运动因子?-一篇综述
Int J Mol Sci. 2025 Aug 23;26(17):8182. doi: 10.3390/ijms26178182.
2
Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的器官间代谢相互作用网络。
Front Endocrinol (Lausanne). 2025 Jan 9;15:1494560. doi: 10.3389/fendo.2024.1494560. eCollection 2024.
3
The Effects of Exercise Interventions on Ectopic and Subcutaneous Fat in Patients with Type 2 Diabetes Mellitus: A Systematic Review, Meta-Analysis, and Meta-Regression.

本文引用的文献

1
Fatty Liver Index and Skeletal Muscle Density.脂肪肝指数与骨骼肌密度
Calcif Tissue Int. 2022 Jun;110(6):649-657. doi: 10.1007/s00223-021-00939-9. Epub 2022 Jan 13.
2
Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial.两种个性化饮食策略对非酒精性脂肪性肝病患者 2 年干预效果的随机试验。
Liver Int. 2021 Jul;41(7):1532-1544. doi: 10.1111/liv.14818. Epub 2021 Mar 1.
3
A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors.
运动干预对2型糖尿病患者异位脂肪和皮下脂肪的影响:一项系统评价、荟萃分析和元回归分析
J Clin Med. 2024 Aug 23;13(17):5005. doi: 10.3390/jcm13175005.
4
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review.脂肪肝指数(FLI)在非酒精性脂肪性肝病管理中的作用:一项系统评价
Diagnostics (Basel). 2023 Oct 26;13(21):3316. doi: 10.3390/diagnostics13213316.
5
Physical Activity as a Lifestyle Modification in Patients With Multiple Comorbidities: Emphasizing More on Obese, Prediabetic, and Type 2 Diabetes Mellitus Patients.将体育活动作为合并多种疾病患者的生活方式干预措施:重点关注肥胖、糖尿病前期及2型糖尿病患者。
Cureus. 2023 Jul 4;15(7):e41356. doi: 10.7759/cureus.41356. eCollection 2023 Jul.
2 型糖尿病患者肌少症的研究进展:患病率及相关因素的叙事性综述
Nutrients. 2021 Jan 9;13(1):183. doi: 10.3390/nu13010183.
4
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship.非酒精性脂肪性肝病与 2 型糖尿病:双向关系。
Can J Gastroenterol Hepatol. 2020 Dec 28;2020:6638306. doi: 10.1155/2020/6638306. eCollection 2020.
5
Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis.2 型糖尿病与肌肉减少症风险增加相关:系统评价和荟萃分析。
Calcif Tissue Int. 2020 Nov;107(5):453-463. doi: 10.1007/s00223-020-00742-y. Epub 2020 Aug 9.
6
Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?非酒精性脂肪性肝病与2型糖尿病:糖尿病专家的立场如何?
Clin Diabetes Endocrinol. 2020 Jun 5;6:9. doi: 10.1186/s40842-020-00097-1. eCollection 2020.
7
Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends.2 型糖尿病的流行病学——全球疾病负担和预测趋势。
J Epidemiol Glob Health. 2020 Mar;10(1):107-111. doi: 10.2991/jegh.k.191028.001.
8
Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review.2 型糖尿病中非酒精性脂肪性肝病的管理:生活方式干预的影响,叙述性综述。
Adv Ther. 2020 Apr;37(4):1381-1406. doi: 10.1007/s12325-020-01281-6. Epub 2020 Mar 7.
9
Lifestyle interventions for non-alcoholic fatty liver disease.非酒精性脂肪性肝病的生活方式干预措施。
Saudi J Biol Sci. 2019 Nov;26(7):1519-1524. doi: 10.1016/j.sjbs.2018.12.016. Epub 2019 Jan 3.
10
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.两种个性化饮食策略对肥胖和非酒精性脂肪性肝病患者代谢和肝脏的影响:肥胖相关性脂肪肝(FLiO)随机对照试验。
Nutrients. 2019 Oct 22;11(10):2543. doi: 10.3390/nu11102543.